Article

Five Ways to Reduce Your Risk of Breast and Ovarian Cancer

Author(s):

Bright Pink

Women begin accumulating risk and establishing their lifestyle behaviors when they are young. What many don’t realize is that they have the power to be advocates for their health by reducing their risk or detecting these diseases at early, non-life-threatening stages.

Bright Pink, a national nonprofit focused on the prevention and early detection of breast and ovarian cancer, outlines 5 actions that young women can take to influence their relative risk of breast and ovarian cancer.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Image of woman.
Related Content
Image of debbie.
June 13th 2025

Survivorship, the Hardest Part After Cancer?

Debbie Legault
Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while building a life she hopes to live fully.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of injection.
June 12th 2025

How Love Helped Me Overcome my Cancer Diagnosis

Glenna Sears-Brinker
Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination to save my life.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Dr. Mabel Mardones educates patients on breast cancer updates: © stock.adobe.com.
June 10th 2025

Understanding Breast Cancer Biomarkers Drives Patient Treatment Decisions

Kristie L. Kahl
Dr. Mabel Mardones educates patients on breast cancer subtypes, as well as treatment options for those with ER-positive, HER2-negative disease.
Image of ovaries.
June 10th 2025

FDA Grants Fast Track Status to PHST001 for Ovarian Cancer Treatment

Spencer Feldman
The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and platinum-sensitive ovarian cancer.